Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
J4V (1r,2r,3s,5r,7r)-N-[(1r)-2-(hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro[1,1'-biphenyl]-4-yl)ethyl]tricyclo[3.3.1.1~3,7~]decane-2-carboxamide
CO3 Carbonate ion
ZN Zinc ion
SO4 Sulfate ion
DMS Dimethyl sulfoxide
1PE Pentaethylene glycol
EDO 1,2-ethanediol
Non-standard Residues
Code Name Show
Glycosylation
Code Name Emphasize
Modification
Code Name Show
Code : 6EEE   PDBj   RCSB PDB   PDBe
Header : hydrolase/hydrolase inhibitor
Title : X-ray crystal structure of Pf-M17 in complex with inhibitor (6k) and regulatory zinc ion
Release Data : 2018-12-26
Compound :
mol_id molecule chains
1 M17 LEUCYL-AMINOPEPTIDASE A,B,C,D,E,F,G,H,I,J,K,L
mutation: N68Q, N431Q, N462Q
Source :
mol_id organism_scientific expression_system
1 Plasmodium falciparum (isolate HB3)  (taxid:137071) Escherichia coli  (taxid:562)
strain: isolate HB3
gene: PFHG_04072
Authors : Drinkwater, N., McGowan, S.
Keywords : M17 LEUCYL-AMINOPEPTIDASE, PROTEASE, INHIBITOR, HYDROXAMIC ACID, hydrolase-hydrolase inhibitor complex
Exp. method : X-RAY DIFFRACTION ( 2.30 Å )
Citation :

Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.

Vinh, N.B.,Drinkwater, N.,Malcolm, T.R.  et al.
(2019)  J. Med. Chem.  62 : 622 - 640

PubMed: 30537832
DOI: 10.1021/acs.jmedchem.8b01310

Chain : A, B, C, D, E, F, G, H, I, J, K, L
UniProt : A0A0L7KHE6 (A0A0L7KHE6_PLAFX)
Reaction: EC: Evidence:
Physiological Direction:
Release of an N-terminal amino acid, Xaa-|-Yaa-, in which Xaa is preferably Leu, but may be other amino acids including Pro although not Arg or Lys, and Yaa may be Pro. Amino acid amides and methyl esters are also readily hydrolyzed, but rates on arylamides are exceedingly low. 3.4.11.1 ARBA:ARBA00000135
-